United StatesBreaking News

Dexcom CEO Jake Leach joined Bloomberg Open Interest to explain why continuous glucose monitors are becoming much bigger than diabetes devices. He says GLP-1 drugs are actually boosting CGM adoption and defends the company's growth outlook. He also lays out Dexcom's push into mainstream metabolic health and wellness.

The Conference Board Senior Economist Erin McLaughlin discusses the latest consumer spending trends amid the recent rise in inflation on "Bloomberg Surveillance."

Bloomberg's Mike McKee discusses the challenges facing incoming Federal Reserve Chair Kevin Warsh on "Bloomberg Open Interest."

Treasury yields are starting to become "unhinged,'' which will be a challenge for incoming Federal Reserve Chair Kevin Warsh, according to Subadra Rajappa, the head of research for Societe Generale Americas. She speaks with Jonathan Ferro and Lisa Abramowicz on Bloomberg Television's "Surveillance.''

After spending time with leaders across Asia and China, Ray Dalio says the perception of American power is shifting fast. Countries that once relied on the US for security are recalibrating toward Beijing, and China sees itself entering a new era of influence rooted in its historical "tribute system." Meanwhile, Dalio says investors tracking the war in Iran are trading on cash flows, not fear, and they need diversification, liquidity, and gold to navigate what comes next.

SambaNova CEO Rodrigo Liang joined Bloomberg  Open Interest to explain why the next AI war won't be about training models, but rather it will be about  inference costs, compute shortages, and who can scale AI infrastructure profitably. In a direct contrast with Cerebras after its blockbuster IPO, Liang breaks down the coming AI supply crunch, exploding enterprise demand, and why inference could become the biggest business in tech.

Arrive AI (NASDAQ:ARAI), a company developing AI-powered autonomous vehicle and robotics solutions, announced its first-quarter 2026 financial results and provided an operational update.

RenX Enterprises (NASDAQ:RENX) reported strong sequential revenue expansion for the first quarter of 2026, driven by higher utilization across its contracted hauling agreements and accelerating bulk material sales, even as advanced technology integration costs left consolidated bottom-line metrics in a deficit.

Creative Realities (NASDAQ:CREX) reported a significant increase in top-line revenue for the first quarter of fiscal 2026, driven primarily by the financial integration of its Cineplex Digital Media acquisition, even as margin compression and one-time structural charges pulled bottom-line metrics into a deficit.

Dan Ives of Wedbush Securities says the Cerebras Systems IPO is a watershed moment for the tech sector. He sees the Nasdaq hitting 30,000 in the next six to nine months. He has more on "Bloomberg Surveillance."

Palvella Therapeutics (NASDAQ:PVLA) reported positive clinical data from its Phase 2 TOIVA trial evaluating its proprietary topical formulation of rapamycin, detailing significant therapeutic benefits for patients suffering from rare vascular skin disorders.

RBC Bearings Incorporated (NYSE:RBC) reported strong financial results for the fourth quarter of fiscal 2026, beating Wall Street expectations as accelerating production rates across commercial aviation and defense programs catalyzed top-line growth.